Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?

In This Article:

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors.

Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.

Is This 1 Momentum Stock a Screaming Buy Right Now?

Different than value or growth investors, momentum-oriented investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

Fresenius (FMS)

Based in Bad Homburg, Germany, Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis following chronic kidney failure.

FMS is a Zacks Rank #2 (Buy) stock, with a Momentum Style Score of B and VGM Score of A. Shares are down 0.3% over the past one week and up 1.7% over the past four weeks. FMS has gained 20.4% in the last one-year period as well. Looking at trading volume, an average of 289,965.06 shares exchanged hands over the last 20 trading days.

A company's earnings performance is important for momentum investors as well. For fiscal 2024, one analyst revised their earnings estimate higher in the last 60 days for FMS, while the Zacks Consensus Estimate has increased $0.01 to $1.52 per share. FMS also boasts an average earnings surprise of 19%.

FMS should be on investors' short list because of its impressive earnings fundamentals, a good Zacks Rank, and strong Momentum and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Fresenius Medical Care AG & Co. KGaA (FMS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research